Anne-Claire HARDY BESSARD, MD
Centre Armoricain d'Oncologie · Clinique Armoricaine de Radiologie
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anne-Claire HARDY BESSARD, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05041842 · Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast CancerUNICANCER · active not recruiting · Metastatic Breast Cancer With a Isolated Brain Progression · principal investigator
- Ph3NCT03079011 · PAlbociclib and Circulating Tumor DNA for ESR1 Mutation DetectionUNICANCER · completed · Metastatic Breast Cancer · principal investigator
- Ph2NCT01941407 · First Line Metastatic Breast Cancer Treatment (ESMERALDA)ARCAGY/ GINECO GROUP · completed · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.